Our investment in healthcare helps us to be more effective by ensuring that healthcare professionals are suitably knowledgeable in the latest therapies and treatment pathways, and that the right facilities exist for medicines to be prescribed and monitored. We also pay healthcare professionals to provide expertise in key areas, for example by taking part in advisory boards or speaking at clinical meetings. We strongly promote the principle of transparency in the financial relationships between pharmaceutical companies and healthcare organisations including health professionals, in accordance with the ABPI Code of Practice for the Pharmaceutical Industry.
Click here to view the data published by Sandoz UK and the Sandoz UK methodological note.
Learn more about the disclosure of payments to healthcare professionals on the ABPI's website.
We believe this transparency is good for everyone:
It allows the public, especially patients, to understand how we work with, and support, the doctors, nurses and patients organisations that care for them. It demonstrates how we use financial and non-financial resources to educate healthcare professionals on how to create better medical outcomes and better access to medicines. It shows how we engage clinicians and other experts to provide vital advisory and consultancy services that we need to do our work more effectively.
We also strongly encourage our healthcare professional colleagues to see the value in this transparency as a way of promoting understanding of our healthcare system and how its many parts work collectively to deliver the best results for patients in the most cost effective way given the limited resources available.